CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Syndax Pharmaceuticals, Inc.

SNDX
$1.55BSmall Cap

Next catalyst

Phase 2December 2026

SNDX-5613

Acute Myeloid Leukemia

Get an email about SNDX's next catalysts

Track Syndax Pharmaceuticals (SNDX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (Phase 2 readout).See the timeline

Catalyst Timeline

3 upcoming, 1 past

Phase 2Next

SNDX-5613 Phase 2 Est. Readout

December 2026~SNDX-561343

Estimated primary completion for SNDX-5613 trial (NCT05360160) in Acute Myeloid Leukemia. Topline data typically follows completion by weeks to months.

Source
Phase 2

Revumenib Phase 2 Est. Readout

December 2026~Revumenib8

Estimated primary completion for Revumenib trial (NCT06284486) in Acute Myeloid Leukemia. Topline data typically follows completion by weeks to months.

Source
Phase 2

Entinostat Phase 2 Est. Readout

June 2027~entinostat47

Estimated primary completion for Entinostat trial (NCT03179930) in Lymphoma. Topline data typically follows completion by weeks to months.

Source

How SNDX's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK270 employees
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Syndax Pharmaceuticals, Inc.'s drug pipeline?→

CatalystAlert tracks 8 drug candidates in Syndax Pharmaceuticals, Inc.'s (SNDX) pipeline across Phase 3, Phase 2. Its lead program is Revumenib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Syndax Pharmaceuticals, Inc.'s next FDA catalyst?→

Syndax Pharmaceuticals, Inc.'s (SNDX) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track SNDX biotech catalysts?→

Add SNDX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Syndax Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply